Wilms' tumour-suppressor protein isoforms have opposite effects on Igf2 expression in primary embryonic cells, independently of p53 genotype
1998

Opposite Effects of Wilms' Tumour-Suppressor Protein Isoforms on Igf2 Expression

publication Evidence: moderate

Author Information

Author(s): A Duarte, A Caricasole, CF Graham, A Ward

Primary Institution: University of Oxford

Hypothesis

Does the p53 protein modulate the transcriptional regulation activity of the Wilms' tumour-suppressor protein (WT1)?

Conclusion

The study found that the two WT1 isoforms have opposite effects on Igf2 expression in primary embryonic cells, independent of p53 genotype.

Supporting Evidence

  • WT1 [-KTS] activates Igf2 P3, whereas WT1 [+KTS] represses its activity.
  • The p53 genotype does not affect WT1 transcriptional activity in these cells.
  • WT1 isoforms were found to have opposite effects on gene expression from a single promoter.

Takeaway

This study shows that two versions of a protein called WT1 can either help or stop a gene from working, and this happens in baby cells that are still growing.

Methodology

The study used primary cell cultures derived from p53 wild-type and knock-out mouse embryos to investigate WT1's effects on Igf2 transcriptional regulation.

Limitations

The study's findings may not apply to all cell types or conditions, as it focused on specific primary embryonic cells.

Participant Demographics

The study involved primary mouse embryonic fibroblasts derived from p53 wild-type and knock-out embryos.

Statistical Information

Statistical Significance

p>0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication